Literature DB >> 22970920

Punishing health care fraud--is the GSK settlement sufficient?

Kevin Outterson1.   

Abstract

Mesh:

Year:  2012        PMID: 22970920     DOI: 10.1056/NEJMp1209249

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective.

Authors:  Peter J Whitehouse
Journal:  Biochem Pharmacol       Date:  2013-12-01       Impact factor: 5.858

2.  Drugs and trials: lessons from Plato.

Authors:  Howard Trachtman
Journal:  Clin Ther       Date:  2013-04-13       Impact factor: 3.393

Review 3.  Ethical diversity and the role of conscience in clinical medicine.

Authors:  Stephen J Genuis; Chris Lipp
Journal:  Int J Family Med       Date:  2013-12-12

Review 4.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

5.  Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.

Authors:  Diane Nguyen; Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Michael Montagne
Journal:  BMC Health Serv Res       Date:  2013-01-22       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.